| Literature DB >> 32705962 |
Shafi Mahmud1, Mohammad Abu Raihan Uddin2, Meemtaheena Zaman2, Khaled Mahmud Sujon1, Md Ekhtiar Rahman1, Mobasshir Noor Shehab1, Ariful Islam1, Md Wasim Alom1, Al Amin3, Al Shahriar Akash4, Md Abu Saleh1.
Abstract
Newly emerged SARS-CoV-2 made recent pandemic situations across the globe is accountable for countless unwanted death and insufferable panic associated with co-morbidities among mass people. The scarcity of appropriate medical treatment and no effective vaccine or medicine against SARS-CoV-2 has turned the situation worst. Therefore, in this study, we made a deep literature review to enlist plant-derived natural compounds and considered their binding mechanism with the main protease of SARS-CoV-2 through combinatorial bioinformatics approaches. Among all, a total of 14 compounds were filtered where Carinol, Albanin, Myricetin were had better binding profile than the rest of the compounds with having binding energy of -8.476, -8.036, -8.439 kcal/mol, respectively. Furthermore, MM-GBSA calculations were also considered in this selection process to support docking studies. Besides, 100 ns molecular dynamics simulation endorsed the rigid nature, less conformational variation and binding stiffness. As this study, represents a perfect model for SARS-CoV-2 main protease inhibition through bioinformatics study, these potential drug candidates may assist the researchers to find a superior and effective solution against COVID-19 after future experiments. Communicated by Ramaswamy Sarma.Entities:
Keywords: MD simulation; Protease inhibitors; binding modes; phytochemicals; virtual screening
Year: 2020 PMID: 32705962 PMCID: PMC7441771 DOI: 10.1080/07391102.2020.1796808
Source DB: PubMed Journal: J Biomol Struct Dyn ISSN: 0739-1102
Docking result (kcal/mol) and binding affinity (kcal/mol) estimation of top 14 candidates.
| PubChem CID | Glide ligand efficiency | XP GScore | Glide evdw | Glide ecoul | Glide energy | Glide emodel | MMGBSA Δ |
|---|---|---|---|---|---|---|---|
| 5280343 | –0.404 | –8.916 | –33.982 | –8.344 | –42.327 | –55.652 | –40.39 |
| 586373 | –0.314 | –8.476 | –33.129 | –12.172 | –45.301 | –59.218 | –46.37 |
| 5281672 | –0.365 | –8.439 | –36.917 | –7.311 | –44.228 | –54.131 | –46.96 |
| 5280681 | –0.354 | –8.178 | –34.079 | –9.163 | –43.243 | –62.916 | –42.02 |
| 5481961 | –0.308 | –8.036 | –35.007 | –10.879 | –45.886 | –60.092 | –49.66 |
| 6476139 | –0.303 | –7.891 | –31.452 | –11.422 | –42.874 | –51.915 | –45.86 |
| 57161864 | –0.464 | –7.996 | –18.869 | –10.685 | –29.555 | –36.942 | –26.61 |
| 439533 | –0.356 | –7.861 | –36.554 | –7.974 | –44.528 | –53.124 | –41.94 |
| 25243950 | –0.32 | –7.678 | –30.95 | –12.212 | –43.161 | –52.839 | –37.1 |
| 5281670 | –0.345 | –7.852 | –34.803 | –5.631 | –40.434 | –52.901 | –34.34 |
| 44258704 | –0.316 | –7.586 | –32.402 | –7.714 | –40.115 | –51.303 | –46.07 |
| 5281855 | –0.341 | –7.565 | –31.108 | –6.149 | –37.257 | –49.183 | –42.26 |
| 5280863 | –0.356 | –7.505 | –33.638 | –7.44 | –41.078 | –52.278 | –38.73 |
| 5281605 | –0.373 | –7.505 | –26.253 | –7.789 | –34.042 | –48.068 | –41.86 |
Non bond interaction between SARS-CoV-2 main protease and top 3 compound.
| PubChem CID | Residues in contact | Interaction type | Distance in Å |
|---|---|---|---|
| 5281672 | ASP187 | Conventional Hydrogen Bond | 2.96 |
| THR26 | Conventional Hydrogen Bond | 1.98 | |
| THR26 | Conventional Hydrogen Bond | 1.91 | |
| MET165 | Carbon Hydrogen Bond | 2.75 | |
| GLN189 | Pi-Donor Hydrogen Bond | 3.2 | |
| MET49 | Pi-alkyl | 5.2 | |
| CYS145 | Pi-alkyl | 5.22 | |
| MET49 | Pi-alkyl | 4.39 | |
| CYS145 | Pi-alkyl | 4.77 | |
| 5481961 | GLY143 | Conventional hydrogen bond | 2.12 |
| GLU166 | Conventional hydrogen bond | 2.33 | |
| ASN142 | Conventional hydrogen bond | 1.98 | |
| THR26 | Conventional hydrogen bond | 1.76 | |
| MET49 | Alkyl | 3.81 | |
| HIS41 | Pi-alkyl | 3.91 | |
| CYS145 | Pi-alkyl | 5.27 | |
| LEU27 | Pi-alkyl | 5.45 | |
| CYS145 | Pi-alkyl | 4.26 | |
| 586373 | GLY143 | Conventional hydrogen bond | 2.37 |
| GLU166 | Conventional hydrogen bond | 2.17 | |
| GLN189 | Conventional hydrogen bond | 3.02 | |
| CYS145 | Conventional hydrogen bond | 2.54 | |
| ARG188 | Conventional hydrogen bond | 2.24 | |
| THR26 | Conventional hydrogen bond | 1.86 | |
| THR25 | Carbon hydrogen bond | 2.99 | |
| GLU166 | Carbon hydrogen bond | 2.54 | |
| THR25 | Carbon hydrogen bond | 2.62 | |
| CYS145 | Pi-sulfur | 5.33 | |
| MET165 | Pi-alkyl | 4.23 |
Figure 1.The figure illustrates different binding modes of selected compounds within the active and catalytic sites of main protease. The alphabetical orders indicate the respective complex of alpha-ketoamide, Carinol, Albanin and Myricetin, respectively. The block and line colors at receptor-ligand interactions such as green, light sky and pink define conventional hydrogen bonding, C-H bonding and hydrophobic interactions, respectively.
Pharmacological properties of the screened compound assessed through admetSAR and PkCSM tools.
| Parameter | Carinol | Myricetin | Albanin |
|---|---|---|---|
| CNS | –2 | –2 | –2 |
| MW | 378.421 | 318.29 | 354.359 |
| SASA | 643.934 | 530.521 | 602.242 |
| Donor HB | 5 | 5 | 3 |
| Acceptor HB | 7.25 | 6 | 4.5 |
| QPlog Poct | 22.094 | 20.824 | 19.224 |
| LogHERG | –4.594 | –5.008 | –5.152 |
| Human Oral absorption | 77.046 | 26.816 | 75.848 |
| Caco2 permeability | –0.174 | 0.095 | –0.449 |
| P-glycoprotein inhibitor | No | No | No |
| BBB permeability | –0.1489 | –1.493 | –1.034 |
| Hepatotoxicity | No | No | No |
| Carcinogenicity | 0.8714(–) | 1.00(–) | 0.957(–) |
| AMES toxicity | No | No | No |
Here, MW: molecular weight; SASA: solvent accessible surface area; CNS: central nervous system activity; LogHERG: predicted Ic50 value for blockage of HERG K+ channels; LogPo/w: predicted octanol/water partition coefficient.
Figure 2.Time series analysis of all the simulated systems. The alphabetical orders from (a) to (d) indicate RMSD analysis of alpha carbon atoms (a), flexibility analysis of amino acid residue (b), protein volume with expansion analysis(c) and degree of rigidity and compactness analysis (d).
Figure 3.Principle component analysis of (a) Apo, (b) Alpha ketoamide-Mpro complex, (c) Carinol-Mpro complex, (d) Albanin-Mpro complex and (e) Myricetin-Mpro complex. Each dot denotes its conformation of the protein throughout the X and Y axis. The spread of blue and red color dots described the degree of conformational changes in the simulation, where the color spectrum from blue to white to red is equivalent to simulation time. The blue specifies the initial timestep, white specifies intermediate, and the final timestep is represented by red color. (f) PCA of trajectory data (RMSD, Rg and SASA) of all systems.